• SENSEX 81,087.69
    -97.89 (--0.12%)
  • BANKNIFTY 55,617.60
    -344.35 (--0.62%)
  • Tata Motors
    647.20 542.55(%)
  • Axis Bank
    1,060.20 934.00(%)
  • Vimta Labs
    677.30 235.00(%)
  • GE Vernova T&D
    2,871.15 2,871.15(%)
  • Netweb Technol.
    2,299.15 3,060.00(%)
  • Suzlon Energy
    66.80 86.04(%)
  • Kaynes Tech
    6,483.00 7,824.95(%)
  • M & M
    3,117.25 2,360.45(%)
  • PNB Housing
    803.30 746.10(%)
  • Waaree Energies
    3,163.55 3,740.75(%)
  • HDFC Bank
    2,010.00 1,593.20(%)
  • Jayaswal Neco
    48.32 26.06(%)
  • Skipper
    548.00 665.00(%)
  • Shree Refrigerat
    177.70 177.70(%)
  • Timex Group
    244.75 289.90(%)
  • Hind. Unilever
    2,728.10 3,034.50(%)
  • TCS
    3,000.00 3,000.00(%)
  • Ceinsys Tech
    1,750.85 538.20(%)
  • Swiggy
    386.25 297.00(%)
  • KIOCL
    374.20 461.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biocon Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 14801.0
  • ISIN : INE376G01013
383.10 -8 (-2.12%)
  • As on 02 Aug 2025 (EOD)

  • Today’s Low

    381.80

  • Today’s High

    392.85

  • Open

    391.50

  • Perv Close

    391.40

  • 52W Low

    291.00

  • 52W High

    406.00

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    51,219.08

  • Div & Yield %

    0.12

  • Book Value(₹)

    119.85

  • Debt-Equity Ratio

    -2.12

  • AGM Date

    01-Aug-2025

  • EPS

    0.34

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    51,219.08

  • RONW (%)

    6.89

  • ROCE (%)

    6.35

Score Board

  • Equity (₹ in Cr.)

    668.48

  • BV (₹)

    119.80

  • Sales( ₹ in Cr.)

    2,242.60

  • NP (in Cr.)

    44.81

  • NP Var(%)

    -58.0

  • Div%

    10.0

  • CPS (₹)

    1.30

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    51,199.02

  • 52 Week High

    406.00

  • 52 Week Low

    291.00

  • Price BSE

    383.0

  • Price NSE

    383.00

  • Market Capital( in Cr.)

    51,199.02

  • P/C Ratio

    296.70

  • P/E Ratio

    1,142.80

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 2,242.60 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,242.60 2,127.30 1,992.90 1,738.20 2,028.40 1,988.40
Other Income 849.80 207.50 3,134.20 187.20 150.20 366.00
Stock Adjustments 54.60 99.10 -3.20 105.80 -36.70 31.40
Total Income 3,147.00 2,433.90 5,123.90 2,031.20 2,141.90 2,385.80
EXPENDITURE :            
Raw Materials 1,085.40 1,033.80 981.00 914.00 761.60 859.10
Power and Fuel Cost 192.00 215.30 279.20 231.00 186.00 193.30
Employee Cost 501.30 452.30 433.80 367.70 390.20 344.80
Other Manufacturing Expenses 163.80 155.40 127.10 130.50 147.00 118.30
Selling and Administration Expenses 172.00 135.00 112.20 106.70 128.40 208.40
Miscellaneous Expenses 6.90 -28.10 32.90 33.00 66.00 9.90
Employee Benefit Expenses 501.30 452.30 433.80 367.70 390.20 344.80
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,121.40 1,963.70 1,966.20 1,782.90 1,679.20 1,733.80
Operating Profit 1,025.60 470.20 3,157.70 248.30 462.70 652.00
Interest 236.90 198.80 69.60 0.40 0.40 1.20
Gross Profit 788.70 271.40 3,088.10 247.90 462.30 650.80
Depreciation 127.80 121.10 116.90 108.20 103.50 98.00
Profit Before Tax 660.90 150.30 2,971.20 139.70 358.80 552.80
Current Tax 30.60 15.10 132.70 60.70 73.50 104.40
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 21.00 15.90 -9.90 -7.10 4.80 7.50
Reported Net Profit 609.30 119.30 2,848.40 86.10 280.50 440.90
Extraordinary Items 564.49 13.41 2,861.73 2.92 3.00 136.27
Adjusted Net Profit 44.81 105.89 -13.33 83.18 277.50 304.63
Adjustment below Net Profit -1.30 30.70 29.40 -59.40 30.40 22.60
P & L Balance brought forward 9,920.50 9,950.60 7,132.80 7,106.10 6,795.20 6,391.80
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 60.00 180.10 60.00 0.00 0.00 60.10
P & L Balance carried down 10,468.50 9,920.50 9,950.60 7,132.80 7,106.10 6,795.20
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 30.00 10.00 0.00 0.00
Dividend Per Share(Rs) 0.50 0.50 1.50 0.50 0.00 0.00
Earnings Per Share-Unit Curr 5.07 0.99 23.72 0.72 2.34 3.67
Earnings Per Share(Adj)-Unit Curr 5.07 0.99 23.72 0.72 2.34 3.67
Book Value 95.98 90.88 90.91 67.40 65.88 62.80
Book Value(Adj)-Unit Curr 95.98 90.88 90.91 67.40 65.88 62.80

Shareholding Pattern

  • Promoter Group

    54.45%

  • Public Share Holding

    45.37%

  • Custodian

    0.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 237,211,164 17.74 237,211,164 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 6,231,042 6,231,042.00 6,231,042 6,231,042
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 243,442,206 18.21 243,442,206 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 484,581,970 36.25 484,581,970 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 484,581,970 36.25 484,581,970 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,200 0.00 1,200 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 80,726,515 6.04 80,726,515 262
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 90,727,877 6.79 90,727,877 18
Mutual Funds / UTI 203,717,668 15.24 203,717,668 32
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 10,713,833 0.80 10,713,833 20
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 385,887,093 28.86 385,887,093 333
2] Non Institution
Bodies Corporate 19,791,395 1.48 19,791,395 1,704
Clearing Members 578,853 0.04 578,853 10
Directors of their Relatives 7,320,441 0.55 7,320,441 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 13,198,283 0.99 12,845,773 9,214
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 5,300,643 0.40 5,300,463 6,769
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 69,364,055 5.19 69,269,075 270
Individuals holding nominal share capital up to Rs. 1 lakh 98,865,560 7.39 98,856,278 409,804
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 438,826 0.03 438,826 15
Others 5,796,017 0.43 5,796,017 4
Sub Total 220,654,073 16.50 220,197,121 427,793
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 2,398,293 0.18 2,398,293 1
Total Shares held by Custodians and against which Depository Receipts have been issued 2,398,293 0.18 2,398,293 1
Grand Total ( A + B + C ) 1,336,963,635 100.00 1,336,506,683 428,131

Company Background

Biocon LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Biocon Ltd
  • BSE Code : 14801.0
  • ISIN : INE376G01013

  • Incorporation Year

    1978

  • Registered Office

    20th KM Hosur Road Hebbagodi
    Electronic City P O, Bangalore,
    Karnataka-560100

  • Telephone

    91-80-28082808

  • FAX

    91-80-28523423

  • Chairman

    Kiran Mazumdar Shaw

  • Managing Director

    SIDDHARTH MITTAL

  • Company Secretary

    Ekta Agarwal

  • Auditor

    B S R & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Biocon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biocon 382.95 2,484.90 2,242.60 83.98 2.07
Abbott India 33,676.00 6,684.73 6,409.15 50.59 44.95
Astrazeneca Phar 8,893.15 1,756.92 1,716.29 192.08 32.94
P & G Health Ltd 6,199.70 1,166.89 1,151.26 40.97 39.76
Glaxosmi. Pharma 2,933.90 3,866.05 3,723.49 52.76 58.72
Cipla 1,501.20 20,029.57 19,044.85 22.44 21.40
Amrutanjan Healt 676.35 437.58 421.23 38.47 20.84
Guj. Themis Bio. 371.85 174.19 169.82 90.92 44.82
Fermenta Biotec. 362.00 442.21 430.53 15.76 17.61
Bliss GVS Pharma 173.70 703.42 667.20 25.96 9.16
Ambalal Sarabhai 32.97 19.33 4.04 30.53 2.10